Brain tumor drug trial halted before starting
NCT ID NCT06012929
Summary
This study aimed to learn about a drug called ONC201 for people with a type of brain tumor (meningioma) that had come back or stopped responding to other treatments. It planned to test the drug in two groups: people scheduled for surgery and people with no other treatment options. The main goals were to see how much of the drug reached the tumor and to measure how long the treatment kept the tumor from getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.